Form 4: CME Group Director Daniel G. Kaye Acquires Shares Under Director Stock Plan

Director Daniel G. Kaye acquired 748 shares of CME Group Inc. common stock under the company's Director Stock Plan.

Summary

• On June 25, 2024, Daniel G. Kaye, a director of CME Group Inc., acquired 748 shares of Class A Common Stock.
• The acquisition was made under the CME Group Director Stock Plan, as amended and restated.
• The price per share was $194.1.
• Following the transaction, Kaye directly owns 4,168 shares of CME Group Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a positive signal, but it's a routine transaction under a pre-existing plan.

Positives

• The acquisition of shares by a director may signal confidence in the company's future prospects.

Industry Context

Acquisitions of company stock by directors are common and can be seen as a positive sign, indicating the director's belief in the company's future performance. These transactions are regulated and require disclosure to ensure transparency.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates